TMC114-TiDP29-C232 - Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir (Rtv) for Children Coming From Any of the Three Ongoing Tibotec Sponsored Pediatric Studies With DRV
Clinical trial NCT01138605 · COMPLETED
Trial details
- NCT number
- NCT01138605
- Sponsor
- Janssen Sciences Ireland UC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-13
- Primary completion
- 2017-11-23
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.